Colo-rectal Cancer
3,584
515
681
1,733
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
404 trials with published results (11%)
Research Maturity
1733 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.5%
270 terminated out of 3584 trials
86.5%
+0.0% vs benchmark
9%
331 trials in Phase 3/4
23%
404 of 1733 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1733 completed trials
Clinical Trials (3584)
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Single-stapled Double Purse-string Technique for Colorectal Anastomosis
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Effect of FMD on Colorectal Cancer Patients
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases
Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection vs. Endoscopic Submucosal Dissection
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer
Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)